Sage Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Sell |
21,303
-195
| -0.9% | -$16.2K | 0.85% | 33 |
|
|
2025
Q1 | $1.74M | Sell |
21,498
-404
| -2% | -$32.8K | 0.95% | 27 |
|
|
2024
Q4 | $1.97M | Sell |
21,902
-1,735
| -7% | -$156K | 1% | 25 |
|
|
2024
Q3 | $2.34M | Sell |
23,637
-904
| -4% | -$89.3K | 1.12% | 24 |
|
|
2024
Q2 | $2.28M | Sell |
24,541
-145
| -0.6% | -$13.4K | 1.2% | 24 |
|
|
2024
Q1 | $2.34M | Hold |
24,686
| – | – | 1.27% | 24 |
|
|
2023
Q4 | $2.2M | Buy |
+24,686
| New | +$2.2M | 1.32% | 23 |
|